RxDoctor Payments Data

Thomas Stricker, MD

Anatomic Pathology · Franklin, TNNPI 1134494784

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.2%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Illumina, Inc. at 39.8% of the total. 2025 is the largest year on record at $8,619, 2.5 times the $3,497 reported in 2022.

$23,939in general payments, 2019–2025

Across 39 payments — averaging $613.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Illumina, Inc.$10K
  • AstraZeneca$8K
  • Johnson & Johnson$5K
  • Janssen Global Services, LLC$1K
  • Tempus AI, Inc$188
  • Novartis$86
  • plus $137 from 3 others
$6,101in research payments, 2019–2025

Across 2 payments — averaging $3050.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$6K

What the payments were for

  • Consulting fees$12,25051%
  • Speaking & faculty fees$4,37418%
  • Travel & lodging$4,60819%
  • Food & beverage$1,7257%
  • Gifts$9694%
  • Entertainment$130%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Illumina, Inc.14$9,527
AstraZeneca9$7,965
Johnson & Johnson7$4,686
Janssen Global Services, LLC1$1,350
Tempus AI, Inc3$188
Novartis1$86
Jazz Pharmaceuticals Inc.1$79
Foundation Medicine, Inc.2$33
Labcorp Holdings Inc.1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,939 in reported general payments places this provider in the 85th percentile of 29 anatomic pathology providers in Tennessee.

See all anatomic pathology providers in Tennessee

Medicare billing

Part B allowed, 2024
$605,636
Medicare patients
385
Services billed
465

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology in Franklin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →